Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 1.000 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.675 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.632 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.631 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.607 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.605 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.604 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.602 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.599 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.596 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.589 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.585 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.578 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.564 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.561 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.559 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.552 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.552 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.551 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.549 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.546 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.541 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.541 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.533 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.531 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.530 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.525 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.524 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.524 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.521 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.520 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.518 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.517 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.517 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.515 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.514 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.513 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.513 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.509 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.508 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.506 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.504 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.504 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.503 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.503 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.503 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.502 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.501 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.500 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.500 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.499 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.499 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.499 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.498 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.497 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.495 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.494 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.493 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.492 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.491 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.491 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.490 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.489 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.489 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.488 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.486 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.485 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.485 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.484 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.484 | |
| 3dtc | VIN | Mitogen-activated protein kinase kinase kinase 9 | 2.7.11.25 | 0.484 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.484 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.484 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.483 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.483 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.482 | |
| 3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.482 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.482 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.481 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.481 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.480 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.480 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.480 | |
| 4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.479 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.478 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.478 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.477 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.477 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.476 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.476 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.476 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.475 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.474 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.474 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.473 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.472 | |
| 4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.472 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.472 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.471 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.471 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.471 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.470 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.470 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.470 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.468 | |
| 4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.468 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.468 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.467 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.466 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.465 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.464 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.464 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.464 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.464 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.463 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.463 | |
| 1m75 | CAA | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.462 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.462 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.462 | |
| 3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.462 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.461 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 3h0s | B38 | Acetyl-CoA carboxylase | / | 0.461 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.461 | |
| 3ori | AGS | Serine/threonine protein kinase | / | 0.461 | |
| 1u5r | ATP | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.460 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.460 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.460 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.460 | |
| 1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.459 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.459 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.459 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 3q5i | ANP | Protein kinase, putative | / | 0.458 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.458 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.458 | |
| 1osv | CHC | Bile acid receptor | / | 0.457 | |
| 1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.457 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
| 4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.457 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.456 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.456 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.455 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 3f88 | 3HT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
| 3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.455 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.455 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.455 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.454 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.454 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.454 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.454 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.454 | |
| 4kuh | CAA | 3-hydroxybutyryl-CoA dehydrogenase | / | 0.454 | |
| 1dhj | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.453 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.453 | |
| 3orm | AGS | Serine/threonine protein kinase | / | 0.453 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.453 | |
| 4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.453 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.453 | |
| 1dkf | BMS | Retinoic acid receptor alpha | / | 0.452 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.452 | |
| 4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.452 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.452 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.452 | |
| 2yaa | ATP | Death-associated protein kinase 2 | / | 0.451 | |
| 3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
| 4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.450 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
| 2qo5 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.450 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.450 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
| 3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
| 3aid | ARQ | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 3inx | JZC | Heat shock protein HSP 90-alpha | / | 0.450 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.450 | |
| 1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
| 2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.449 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.449 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.449 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.449 | |
| 1sgu | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.448 | |
| 4j16 | NAD | NAD/NADP transhydrogenase alpha subunit 1 | / | 0.448 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.447 | |
| 3ict | COA | Coenzyme A disulfide reductase | / | 0.447 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
| 4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.447 | |
| 4wa9 | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.447 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.446 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 3upj | U03 | Gag-Pol polyprotein | / | 0.446 | |
| 4a6b | QG8 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.446 | |
| 4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.445 | |
| 2aaz | CB3 | Thymidylate synthase | 2.1.1.45 | 0.445 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 3ndr | NAD | Pyridoxal 4-dehydrogenase | 1.1.1.107 | 0.445 | |
| 3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
| 2x3n | FAD | Probable FAD-dependent monooxygenase | / | 0.444 | |
| 3aox | EMH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.444 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.444 | |
| 3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 4a9t | A9T | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.444 | |
| 4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.444 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.444 | |
| 1ie4 | T44 | Transthyretin | / | 0.443 | |
| 3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.443 | |
| 1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
| 2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.442 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 3mg3 | ECH | Orange carotenoid-binding protein | / | 0.442 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.442 | |
| 3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.442 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.442 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.442 | |
| 4y8w | STR | Steroid 21-hydroxylase | / | 0.442 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 1fwk | ADP | Homoserine kinase | 2.7.1.39 | 0.441 | |
| 2ykb | YKB | Heat shock protein HSP 90-alpha | / | 0.441 | |
| 2ykj | YKJ | Heat shock protein HSP 90-alpha | / | 0.441 | |
| 2z7q | ACP | Ribosomal protein S6 kinase alpha-1 | 2.7.11.1 | 0.441 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.441 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
| 5auu | LU2 | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
| 1l3i | SAH | Probable cobalt-precorrin-6B C(15)-methyltransferase (decarboxylating) | / | 0.440 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.440 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4dfr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
| 4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4wq4 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.440 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.440 |